Merck Sharp & Dohme Ltd.

London

1 studies enrolling now · 1 studies all time

What they study most

Classical Hodgkin Lymphoma, Lymphoma, Melanoma, Microsatellite-instability-high Solid Tumor, Solid Tumor

Studies at this site

• A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) — Recruiting now